AD1503 – Alzheimer’s disease

AD1503 is an innovative project to develop a disease modifying treatment for prodromal and mild Alzheimer’s disease. It is an antibody project against a shorter (truncated) form of amyloid beta, which has a pronounced ability to aggregate and create toxic forms that could cause Alzheimer’s disease.